MedPath

Prednisolone acetate

Generic Name
Prednisolone acetate
Brand Names
Blephamide, Econopred Plus, Flo-pred, Pred Forte, Pred Mild, Pred-G
Drug Type
Small Molecule
Chemical Formula
C23H30O6
CAS Number
52-21-1
Unique Ingredient Identifier
8B2807733D

Overview

Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond. Prednisolone acetate was granted FDA approval in 1955.

Background

Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond. Prednisolone acetate was granted FDA approval in 1955.

Indication

Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions. Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.

Associated Conditions

  • Inflammation
  • Inflammatory Conditions
  • Ocular Infections, Irritations and Inflammations
  • Ocular Inflammation
  • Transplanted Organ Rejection

FDA Approved Products

BLEPHAMIDE
Manufacturer:Physicians Total Care, Inc.
Route:OPHTHALMIC
Strength:2 mg in 1 mL
Approved: 2013/11/15
NDC:54868-0634
PREDNISOLONE ACETATE
Manufacturer:H.J. Harkins Company, Inc.
Route:OPHTHALMIC
Strength:10 mg in 1 mL
Approved: 2011/11/17
NDC:52959-265
PREDNISOLONE ACETATE
Manufacturer:A-S Medication Solutions
Route:OPHTHALMIC
Strength:10 mg in 1 mL
Approved: 2023/01/13
NDC:50090-1912
Prednisolone Acetate
Manufacturer:Sandoz Inc
Route:OPHTHALMIC
Strength:10 mg in 1 mL
Approved: 2016/01/20
NDC:61314-637
PREDNISOLONE ACETATE
Manufacturer:DIRECT RX
Route:OPHTHALMIC
Strength:10 mg in 1 mL
Approved: 2019/10/30
NDC:72189-055

Singapore Approved Products

PRED FORTE OPHTHALMIC SUSPENSION 1%
Manufacturer:ALLERGAN PHARMACEUTICALS IRELAND
Form:SOLUTION
Strength:10 mg/ml
Online:Yes
Approved: 1990/06/13
Approval:SIN04661P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath